Christina Gavegnano

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019

Boghuma K Titanji, Monica M. Farley, Ashish Mehta et al. · Clinical Infectious Diseases · 2020 · 141 citations · Full text

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages

Edward M. Kennedy, Christina Gavegnano, Laura A. Nguyen et al. · Journal of Biological Chemistry · 2010 · 101 citations · Full text

Viral Replication, Biochemistry, Human Macrophages +10

Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation <i>In Vitro</i>

Christina Gavegnano, Mervi Detorio, Catherine Montero et al. · Antimicrobial Agents and Chemotherapy · 2014 · 100 citations · Full text

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

Christina Gavegnano, Jessica H. Brehm, Franck P. Dupuy et al. · PLoS Pathogens · 2017 · 98 citations · Full text

Immune Regulation, Immunology, Immunodominance +25

The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model

Woldeab B. Haile, Christina Gavegnano, Sijia Tao et al. · Neurobiology of Disease · 2016 · 83 citations · Full text

Human Macrophages, Medicine, Murine Model +10